CAS 556743-18-1
MT
CAS 556743-18-1
CAS 556743-18-1
| Availability: | |
|---|---|

Lumbokinase capsules attenuates myocardial ischemia-reperfusion (I-R) injury through the activation of Sirt1 signaling, and thus enhances autophagic flux and reduces I-R-induced oxidative damage, inflammation and apoptosis[1].
| Description | Lumbokinase capsules attenuates myocardial ischemia-reperfusion (I-R) injury through the activation of Sirt1 signaling, and thus enhances autophagic flux and reduces I-R-induced oxidative damage, inflammation and apoptosis[1]. |
|---|---|
| Related Catalog | |
| Target | SIRT1 |
| References | [1]. Wang YH, et, al. Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protec |

Packing and Shipping:



Lumbokinase capsules attenuates myocardial ischemia-reperfusion (I-R) injury through the activation of Sirt1 signaling, and thus enhances autophagic flux and reduces I-R-induced oxidative damage, inflammation and apoptosis[1].
| Description | Lumbokinase capsules attenuates myocardial ischemia-reperfusion (I-R) injury through the activation of Sirt1 signaling, and thus enhances autophagic flux and reduces I-R-induced oxidative damage, inflammation and apoptosis[1]. |
|---|---|
| Related Catalog | |
| Target | SIRT1 |
| References | [1]. Wang YH, et, al. Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protec |

Packing and Shipping:

